申请人:CANCER REC TECH LTD
公开号:WO2014037750A1
公开(公告)日:2014-03-13
The present invention relates to compounds of formula (I), wherein R, R, Ar, W, X and Z are all as defined herein. The compounds of the present invention are known to inhibit the spindle checkpoint function of Monospindle 1 (Mps1 – also known as TTK) kinases either directly or indirectly via interaction with the Mps1 kinase itself. In particular, the present invention relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of these compounds, and to pharmaceutical compositions comprising them.
本发明涉及式(I)的化合物,其中R、R、Ar、W、X和Z均如本文所定义。本发明的化合物已知可以通过直接或间接地与Mps1激酶本身相互作用来抑制单丝粒体1(Mps1,也称为TTK)激酶的纺锤体检查点功能。具体而言,本发明涉及将这些化合物用作治疗和/或预防增殖性疾病,如癌症的治疗剂。本发明还涉及制备这些化合物的方法,以及包含它们的药物组合物。